Showing 191-200 of 516 results for "".
Forward Thinking: Advances in Neurology
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/forward-thinking-advances-in-neurology/30305/A review of notable neurological developments in 2017 and a preview of the year ahead.The Approval of PFO Closure in the United States
https://practicalneurology.com/diseases-diagnoses/stroke/the-approval-of-pfo-closure-in-the-united-states/30295/A look back at the long road to FDA approval and the implications on patient care options going forward.Patient-Centric Innovations in MS Care: High-Efficacy DMT’s, Cognition, and Special Patient Populations
https://practicalneurology.com/programs/cme/patient-centric-innovations-in-ms-care-high-efficacy-dmts-cognition-and-special-patient-populations/29172/Learn more about the use of high-efficacy DMTs in multiple sclerosis.Improving Outcomes Earlier in Generalized Myasthenia Gravis: Roadmap for Incorporating Targeted Therapies Into Clinical Practice
https://reachmd.com/programs/cme/improving-outcomes-earlier-in-generalized-myasthenia-gravis-roadmap-for-incorporating-targeted-therapies-into-clinical-practice/29145/While traditional gMG treatments bring many debilitating side effects, a more targeted approach focusing on the FcRn complex has shown great promise.Patient-Centric Innovations in MS Care: High-Efficacy DMTs, Cognition, and Special Patient Populations
https://practicalneurology.com/programs/cme/patient-centric-innovations-in-ms-care-high-efficacy-dmts-cognition-and-special-patient-populations/29171/Tune in to learn more about the use of high-efficacy DMTs in multiple sclerosis.Preserving Memory: Tips to Help Baby Boomers Stay in the Game
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/PN0309_03-php/30934/Middle-aged patients may unnecessarily fear dementia. These 10 tips can help preserve cognitive function.Medical Aid in Dying: An Overview for Neurologists
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/medical-aid-in-dying-an-overview-for-neurologists/35442/Life-limiting neurologic diseases can result in decreased quality of life despite excellent interdisciplinary care, and neurologists must be prepared for individuals with unrelieved suffering to make requests for hastened death.Convention Question: What Will Drive the Next Great Advance in Stroke Treatment?
https://practicalneurology.com/diseases-diagnoses/stroke/convention-question-what-will-drive-the-next-great-advance-in-stroke-treatment/30121/Answers from attendees of the International Stroke Conference in Honolulu, HI, Feb 6th-8th, 2019.- Dr. Elizabeth Leroux, McGill University, Highlights Key Articles in Headache Literature from 2022-2023https://practicalneurology.com/news/dr-elizabeth-leroux-mcgill-university-highlights-key-articles-in-headache-literature-from-2022-2023/2470345/On the final day of the 2023 Scottsdale Headache Symposium, Dr. Elizabeth Leroux, Past President of the Canadian Headache Society, presented a review of the state of headache literature from 2022 through 2023. Dr. Leroux outlined key areas in scientific publications focusing on the following area
- CTAD 2025 Honors Takeshi Iwatsubo, MD, PhD with Lifetime Achievement Awardhttps://practicalneurology.com/news/ctad-2025-honors-takeshi-iwatsubo-md-phd-with-lifetime-achievement-award/2484692/Takeshi Iwatsubo, MD, PhD was recognized at the 18th annual Clinical Trials on Alzheimer’s Disease (CTAD) conference as the recipient of this year’s Lifetime Achievement Award in Alzheimer’s Disease Therapeutic Research. The award celebrates Dr. Iwatsubo’s decades of foundational work in Alzheime